Синтез наркотиков [A]

MDMB-5Br-INACA Review

What is MDMB-5Br-INACA?

MDMB-5Br-INACA is classified as a synthetic cannabinoid. MDMB-5Br-INACA is used as a precursor in the synthesis of synthetic cannabinoids. It has been sold online as "half finished" synthetic cannabinoids, sometimes as a "chemistry kit" with other compounds required to complete the reaction. This reaction would complete MDMB-5Br-INACA by giving it a "tail" group required for high cannabinoid activity.

Vh4Fl3JcG6.png Закрыть Открыть: Vh4Fl3JcG6.png

Synthetic cannabinoids have psychoactive effects similar to delta-9-tetrahydrocannabinol (THC). However, little to no information is currently known about the activity, potency, and/or toxicity of MDMB-5Br-INACA. New synthetic cannabinoids continue to emerge among the recreation drug supply internationally, seemingly as replacements after a synthetic cannabinoid class-wide ban implemented by China in July 2021 which included most traditional indole and indazole structural scaffolds. Many of these new synthetic cannabinoid analogues are studies with pharmacological and human effects undetermined. Currently, MDMB-5Br-INACA is not a scheduled substance in the United States.

2hI5UvxeJR.png Закрыть Открыть: 2hI5UvxeJR.png

Other precursors lacking a tail chain have also been marketed such as ADB-5'Br-BINACA, ADB-5'Br-BUTINACA, ADB-5-Br-INACA, CH-IATA, ADB-IACA, and ADB-5’Br-EZO-CA. This may be due to increasing legality changes worldwide on synthetic cannabinoids.

Physico-chemical Properties

Molecular Formula: C15H18BrN3O3;
Molar mass: 368.231 g/mol;
Names: methyl (S)-2-(5-bromo-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate; MDMB-5-bromo-INACA; 5Br-MDMB-INACA; Methyl 2-[(5-bromo-1H-indazole-3-carbonyl)amino]-3,3-dimethyl- butanoate;
Form: solid substance;
Storage: -20°C;
Stability: ≥5 years;

Solubility

DMF: 14 mg/mL;
DMSO: 14 mg/mL;
Ethanol: 14 mg/mL;
PBS (pH 7.2): 0.20 mg/mL;

Legality

In the United States, MDMB-5Br-INACA is unscheduled at the federal level as of May 22nd, 2023.

North Dakota has placed MDMB-5Br-INACA (along with ADB-5'Br-BINACA, ADB-5'Br-BUTINACA and ADB-5-Br-INACA) into Schedule I on 04/27/2023.

Источник: http://bbzzzsvqcrqtki6umym6itiixfhni37ybtt7mkbjyxn2pgllzxf2qgyd.onion/threads/mdmb-5br-inaca-review.8019/

↑ 3

Обсуждение

Комментарии

5

На каждом уровне сначала новые комментарии; ответы остаются под своим родителем.

Написать Join — чтобы участвовать в обсуждении.

the part readers will skip past is that it's incomplete. a tail-less precursor sold as a kit is a box of rabbit holes for anyone without a fume hood, and "not scheduled in the US" isn't the same as "safe to handle". the north dakota carve-out is a good reminder of how patchy this is state by state.
what gets me is the unfinished product — selling a tailless indazole as a kit and leaving the buyer to work out the ester/amide step is a reliable way to produce a batch that does nothing. A few of these no-tail precursors have surfaced since the 2021 bans, and the labs behind them don't appear to check whether anyone knows the chemistry.
The tailless-precursor angle is the one to flag. Buyers expect something smokeable and then wonder why nothing happens — no tail means essentially no cb1 activity, so it's a chemistry project rather than a high. The solubility numbers are also ethanol/dmso only, pbs is practically insoluble.
worth flagging that the "chemistry kit" framing is the part to worry about. a precursor that's legal because it has no tail still sitting in a bag on someone's desk invites the owner to finish the job themselves, and nobody's publishing the toxicity data for the finished thing either.
the "half finished" chemistry kit angle deserves a flag — that reaction adds a tail, and anyone running it has no potency data whatsoever, so guessing a dose is roulette. worth adding that ND has it schedule I while other states don't, the usual patchwork with analogue classes.